Literature DB >> 7073147

Occult cancer in patients with acute pulmonary embolism.

J M Gore, J S Appelbaum, H L Greene, L Dexter, J E Dalen.   

Abstract

An association between venous thrombosis and cancer was first suggested by Trousseau, and has been confirmed by multiple postmortem studies. Clinical studies have shown that thrombophlebitis migrans may occur before malignancies become clinically evident, and therefore serves as a clue to occult cancer. A relation between occult cancer and the commoner deep venous thrombosis and pulmonary embolism has not been established. We ascertained the incidence of cancer before and after pulmonary embolism was diagnosed by pulmonary angiography in 128 patients. The incidence of cancer before pulmonary embolism (12%) was essentially the same as that in a comparison group of patients without pulmonary embolism (10%). In the 2 years after pulmonary angiography, however, cancer was diagnosed in 13 patients with pulmonary embolism in contrast to no patients in the comparison group (p less than 0.001). The most frequent cancers involved the lung, gastrointestinal tract, breast, and uterus. The malignancies were nearly always occult when pulmonary embolism occurred. These findings indicate that pulmonary embolism with or without overt deep venous thrombosis should alert the clinician to consider occult cancer.

Entities:  

Mesh:

Year:  1982        PMID: 7073147     DOI: 10.7326/0003-4819-96-5-556

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  8 in total

1.  Should we look further for cancer in a patient with venous thromboembolism?

Authors:  D E Arterburn; W S Richardson
Journal:  West J Med       Date:  2000-05

Review 2.  Common emergencies in cancer medicine: hematologic and gastrointestinal syndromes.

Authors:  C R Thomas; I K Carter; W T Leslie; F Sutton
Journal:  J Natl Med Assoc       Date:  1992-02       Impact factor: 1.798

Review 3.  Encephalomalacia/gliosis, deep venous thrombosis, and cancer in Arg393His antithrombin Hanoi and the potential impact of the β-amyloid precursor protein (APP) on thrombosis and cancer.

Authors:  Khue Vu Nguyen
Journal:  AIMS Neurosci       Date:  2022-04-21

Review 4.  Fibrin as a component of the tumor stroma: origins and biological significance.

Authors:  H F Dvorak; D R Senger; A M Dvorak
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

5.  Clues to occult cancer in patients with ischemic stroke.

Authors:  Suk Jae Kim; Jae Hyun Park; Mi-Ji Lee; Yun Gyoung Park; Myung-Ju Ahn; Oh Young Bang
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

6.  Validation of a prognostic score for hidden cancer in unprovoked venous thromboembolism.

Authors:  Luis Jara-Palomares; Remedios Otero; David Jimenez; Juan Manuel Praena-Fernandez; Carme Font; Conxita Falga; Silvia Soler; David Riesco; Peter Verhamme; Manuel Monreal
Journal:  PLoS One       Date:  2018-03-20       Impact factor: 3.240

Review 7.  Haemostasis in malignant disease.

Authors:  M J Auger; M J Mackie
Journal:  J R Coll Physicians Lond       Date:  1988-04

8.  Insights into venous thromboembolism prevention in hospitalized cancer patients: Lessons from a prospective study.

Authors:  Rocío Figueroa; Ana Alfonso; José López-Picazo; Ignacio Gil-Bazo; Alberto García-Mouriz; José Hermida; José Antonio Páramo; Ramón Lecumberri
Journal:  PLoS One       Date:  2018-08-02       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.